DK1256581T3 - Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation - Google Patents

Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation

Info

Publication number
DK1256581T3
DK1256581T3 DK01902793T DK01902793T DK1256581T3 DK 1256581 T3 DK1256581 T3 DK 1256581T3 DK 01902793 T DK01902793 T DK 01902793T DK 01902793 T DK01902793 T DK 01902793T DK 1256581 T3 DK1256581 T3 DK 1256581T3
Authority
DK
Denmark
Prior art keywords
group
preventive
oesophageal
regurgitation
gastric
Prior art date
Application number
DK01902793T
Other languages
English (en)
Inventor
Satoshi Yamazaki
Original Assignee
Dynogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynogen Pharmaceuticals Inc filed Critical Dynogen Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1256581T3 publication Critical patent/DK1256581T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01902793T 2000-02-09 2001-02-07 Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation DK1256581T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000031542 2000-02-09
PCT/JP2001/000852 WO2001058898A1 (en) 2000-02-09 2001-02-07 Preventive or therapeutic agents for gastric or esophageal regurgitation

Publications (1)

Publication Number Publication Date
DK1256581T3 true DK1256581T3 (da) 2007-09-24

Family

ID=18556282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902793T DK1256581T3 (da) 2000-02-09 2001-02-07 Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation

Country Status (13)

Country Link
US (7) US6967207B2 (da)
EP (1) EP1256581B1 (da)
JP (1) JP4781592B2 (da)
KR (1) KR100750437B1 (da)
AT (1) ATE358128T1 (da)
AU (1) AU2001230588A1 (da)
CA (1) CA2399818C (da)
DE (1) DE60127535T2 (da)
DK (1) DK1256581T3 (da)
ES (1) ES2284612T3 (da)
PT (1) PT1256581E (da)
TW (1) TWI256314B (da)
WO (1) WO2001058898A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
PT1419772E (pt) * 2001-08-24 2007-09-05 Dynogen Pharmaceuticals Inc Agente preventivo/agente terapêutico papa ibs com predominância de obstipação.
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
HUP0402289A2 (hu) * 2001-10-02 2005-02-28 Pharmacia & Upjohn Company Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR038294A1 (es) * 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
WO2008153884A1 (en) * 2007-06-07 2008-12-18 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastroesophageal reflux disease
AU2010273732A1 (en) * 2009-07-14 2012-02-09 Albany Molecular Research, Inc. 5-HT3 receptor modulators, methods of making, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829073A (en) * 1988-05-12 1989-05-09 Bristol-Myers Company Thiadiazole oxides for treating gastrointestinal motility disorders
IE903747A1 (en) * 1989-10-19 1991-04-24 Searle & Co Method of treating gastrointestinal motility disorders
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease

Also Published As

Publication number Publication date
US20100168157A1 (en) 2010-07-01
JP4781592B2 (ja) 2011-09-28
EP1256581B1 (en) 2007-03-28
ES2284612T3 (es) 2007-11-16
TWI256314B (en) 2006-06-11
KR100750437B1 (ko) 2007-08-21
ATE358128T1 (de) 2007-04-15
WO2001058898A1 (en) 2001-08-16
CA2399818A1 (en) 2001-08-16
US6967207B2 (en) 2005-11-22
KR20020089340A (ko) 2002-11-29
US20050282852A1 (en) 2005-12-22
US20060281781A1 (en) 2006-12-14
DE60127535D1 (de) 2007-05-10
PT1256581E (pt) 2007-06-26
US20030130304A1 (en) 2003-07-10
CA2399818C (en) 2010-01-12
AU2001230588A1 (en) 2001-08-20
EP1256581A1 (en) 2002-11-13
US20100204267A1 (en) 2010-08-12
US20100210679A1 (en) 2010-08-19
US20080293762A1 (en) 2008-11-27
EP1256581A4 (en) 2004-10-06
DE60127535T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
SE0104332D0 (sv) Therapeutic agents
DK1065204T3 (da) Bicykliske carbonyl-indolforbindelser som anti-inflammatoriske/analgesiske midler og som COX-2-inhibitorer
JP2004507521A5 (da)
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
IL150965A0 (en) Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
NO985202D0 (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
ATE293961T1 (de) Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
AR040202A1 (es) Combinacion de un agente inhibidor de la secrecion de acido y un inhibidor de reflujo para el tratamiento de la gerd
PT1386608E (pt) Agente terapêutico para doença glomerular
WO2007000392A3 (en) Chloro-substituted guanidines
EP1393727A4 (en) MEANS FOR THE TREATMENT OF MYELOPATHY
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract